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ABSTRACT
DNA aptamers RT5, RT6 and RT47 form a group
of related sequences that inhibit HIV-1 reverse
transcriptase (RT). The essential inhibitory structure
is identified here as bimodular, with a 5’ stem–loop
module physically connected to a 3’-guanosine
quadruplex module. The stem–loop tolerates con-
siderable sequence plasticity. Connections between
the guanosine triplets in the quadruplex could be
simplified to a single nucleotide or a nonnucleic
acid linker, such as hexaethylene glycol. All 12 quad-
ruplex guanosines are required in an aptamer retain-
ing most of the original loop sequence from RT6;
only 11 are required for aptamer R1T (single T resi-
due in intra-quadruplex loops). Circular dichroism
(CD) spectroscopy gave ellipticity minima and
maxima at 240nm and 264nm, indicating a parallel
arrangement of the quadruplex strands. The simpli-
fied aptamers displayed increased overall stability.
An aptamer carrying the original intra-quadruplex
loops from RT6 inhibited RT in K
1 buffers but not
in Na
1 buffers and displayed significant CD spectral
broadening in Na
1 buffers, while R1T inhibited RT in
both buffers and displayed less broadening in Na
þ
buffers. The bimodular ssDNA aptamers inhibited
RT from diverse primate lentiviruses with low nM
IC50 values. These data provide insight into the
requirements for broad-spectrum RT inhibition by
nucleic acid aptamers.
INTRODUCTION
Antiviral chemotherapy has achieved spectacular results
in prolonging the survival of patients infected with
HIV-1. Morbidity and mortality related to HIV-1 have
dramatically declined in developed countries, converting
HIV infection into a treatable chronic disease. However,
current antiviral drugs do not eradicate the virus, and
prolonged treatment can have serious side eﬀects and
select drug-resistant viral strains (1). In addition, millions
of new infections occur worldwide each year (2,3).
Continued eﬀorts toward the discovery of new antiviral
strategies therefore remain imperative.
The reverse transcriptase (RT) of HIV-1 is a primary
target for inhibition by current drugs, which include
the nucleoside analog RT inhibitors (NRTIs, primarily
chain terminators) and the nonnucleoside RT inhibitors
(NNRTIs, noncompetitive allosteric inhibitors of poly-
merization by RT). Nucleic acid aptamers comprise a
third class of RT inhibitors. Because many aptamers com-
pete with the template/primer duplex for access to the
enzyme (4–6), they have been referred to as TRTIs (tem-
plate/primer analog RT inhibitors) (7). Aptamers are
derived from the combinatorial method of in vitro selec-
tion, or SELEX (for Selective Evolution of Ligands by
EXponential enrichment). Numerous aptamers have
been identiﬁed that bind RT with high aﬃnity and that
inhibit its enzymatic activity in vitro (4,5,8–15) [reviewed
in (16)]. Several of these aptamers have also been demon-
strated to interfere with viral replication in cell culture
(7,12,15,17,18). Clinical application of RNA aptamers
may eventually take the form of gene therapy, wherein
genes that direct the expression of the therapeutic aptamer
are delivered to target cells (e.g. CD34
þ stem cells) for
intracellular expression. Direct clinical application of
DNA aptamer inhibitors of RT will require further
improvements in delivery to the appropriate target cells.
However, both RNA and DNA aptamers are valuable
research tools for dissecting the molecular mechanisms
of viral replication and pathogenesis.
While both RNA and DNA aptamers to RT have been
described, DNA aptamers oﬀer several unique advantages
and opportunities. (i) They can be synthesized at large
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able worldwide. (ii) DNA aptamers can be stored in desic-
cated form for years, then be refolded and fully activated
upon rehydration, and their shelf-life can be further pro-
longed by storage in the presence of metal chelators, such
as EDTA. (iii) Chemical derivatization can be readily
accomplished by existing synthetic methods to adapt a
given aptamer to a variety of delivery and diagnostic plat-
forms. (iv) Nucleic acids are generally nonimmunogenic,
so their repeated use is unlikely to induce an inﬂammatory
immune response. (v) Several recent studies with RT
mutants—including drug-resistant RT (19,20)—and with
RT from phylogenetically diverse virus (14) suggest that
the genetic threshold for the development of signiﬁcant
resistance to some ssDNA aptamers may be very high.
Five sets of ssDNA aptamers to HIV-1 RT have been
described. The present study builds from the aptamer set
selected by Schneider et al. (11), who identiﬁed at least
seven sequence families from among 30 aptamer isolates.
Several aptamers from this set strongly inhibit the
RNA-dependent DNA polymerase activity of HIV-1 RT
and bind RT with dissociation constant (Kd) values near
1nM (11). We recently demonstrated that a 49-nt version
of aptamer RT1, designated RT1t49, inhibits RT from
diverse strains of HIV-1, HIV-2 and SIVcpz (a close rela-
tive of HIV-1 that infects chimpanzees) (14). Mutational
and footprinting analysis, combined with molecular mod-
eling, support a two-helix structure for RT1t49 in which
one helix occupies the primer/template-binding cleft in the
protein and the other helical structural unit is thought to
interact with the back side of the ﬁngers or thumb domain
(5). Other work has evaluated the inﬂuence of speciﬁc RT
point mutations on binding by RT1t49 and several other
aptamers (19,20). Although some progress has been made
in identifying how the RT1 family of ssDNA aptamers
interacts with HIV-1 RT, relatively little is known about
the other structural families from this set.
The second set of ssDNA aptamers, isolated by
Andreola et al. (12), was targeted to interact with the
RNase H domain of RT by utilizing alternate cycles of
positive selection for binding to the p66/p51 heterodimer
with cycles of negative selection to remove aptamers
binding the p51/p51 homodimer. Two species from this
selection, designated ODN93 and ODN112, inhibit both
DNA polymerization and RNase H activities in vitro
with half-maximal inhibitory values (IC50) of 500nM.
When added to cell culture simultaneously with virus,
these same DNAs interfered with viral infectivity. Trun-
cated version of these anti-RNase H aptamers, designated
93del and 112del, both form guanosine quadruplex
structures. Both molecules also cross-react with HIV-1
integrase, blocking both ‘end-processing’ and strand-
insertion activities by integrase, with IC50 values in these
reactions as low as 10–100nM (21).
The other three aptamer sets each have distinct features.
DeStefano and Cristaforo (13) selected GC-rich duplexes
with recessed 30-ends that resemble the primer/template
substrate utilized by the virus during (þ)-strand genome
synthesis. Somasunderam et al. (15) used combinatorial
bead chemistry to identify sulfur-containing thioaptamers
that bind RT with Kd values as low as 70nM and that
interfere with viral replication in cell culture. Several of
these DNAs are G-rich and have the potential to form
quadruplex structures (15). More recently, Bowser and
colleagues (22) used capillary electrophoresis to eﬀect the
rapid selection of ssDNA aptamers with especially high
aﬃnity for HIV-1 RT (Kd¼0.18nM).
The aptamers from the ﬁve selections above comprise a
highly diverse collection of sequences and secondary struc-
tures, including several that form guanosine quadruplex
structures. Quadruplexes are a highly stable, multi-layer
fold in which four guanosines within a given layer hydro-
gen bond from the Watson–Crick face of each guanosine
to the Hoogsteen face of another guanosine, and succes-
sive layers stack together [reviewed in (23)]. Sequences
capable of forming quadruplex structures are found
in human (24) and Oxytricha nova (25) telomeres, and in
several promoter sequences (26–32). Recent advances in
quadruplex aptamer identiﬁcation, characterization and
delivery have led to increased interest in developing
them as tools for modulating biology. For example,
ssDNA aptamers to the blood clotting factor thrombin
(33) and to insulin (34) both form quadruplexes and
have been studied extensively. AS1411 is a quadruplex-
forming DNA aptamer that targets nucleolin and that
is currently in clinical trials as a treatment for various
cancers (35), and several DNA quadruplexes have shown
potent inhibition of HIV-1 integrase (36,37).
In the present work, we reinvestigated several molecules
from the Schneider set of ssDNA aptamers selected to
bind HIV-1 RT (11). Three aptamers demonstrate bimod-
ular structure comprising quadruplex and helical elements.
Both elements are required for RT inhibition, and they
must be physically connected. We ﬁnd that there are rela-
tively few sequence constraints within either element or in
the connection between them, and the chemical nature of
the linkages between the two major structural elements
and within the quadruplex played no signiﬁcant roles in
determining inhibition of HIV-1 RT. Importantly, the
bimodular aptamer exhibited potent inhibition of RT
derived from phylogentically diverse HIV and SIV strains.
Our ﬁndings aid in understanding the mechanism of HIV
RT inhibition utilizing structured DNA inhibitors and
reinforce the potential clinical and research value of quad-
ruplex DNA aptamers.
MATERIALS AND METHODS
RTand DNA oligonucleotides
RT were expressed in Escherichia coli and puriﬁed as
described in (4). Except where noted, all assays utilized
RT from HIV-1 strain HXB2 (group M, subtype B).
Aptamer RT6 was synthesized and puriﬁed by Operon
Biotechnologies, Inc., (Huntsville, AL, USA; www.
operon.com). All other aptamer oligonucleotides and
primer/template substrates were synthesized and
puriﬁed by Integrated DNA Technologies, Inc. (www.
idtdna.com). The original full-length aptamers were 81nt
in length (11). The ‘full-length’ aptamers studied here were
synthesized as 80-nt molecules by removing the 30-terminal
dG residue. This change was without functional
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sured previously (11). Computational predictions of DNA
secondary structures with mfold 3.1 (www.rpi.edu/
 zukerm/) (38,39) utilized only the nonquadruplex por-
tions of each molecule. All oligonucleotides used in this
study are given in Table 1.
Inhibition of RTenzymatic activities
Aptamer DNA was denatured by heating to 958C for
5min, followed by slow cooling at a rate of 28 per minute
to room temperature and stored in frozen condition. Sub-
sequent dilutions were made from this refolded stock
without additional refolding. Measurements of DNA-
dependent DNA polymerization (DDDP) were carried
out essentially as described (4). For DDDP assays, an 18-
nt Cy3-labeled DNA primer was annealed to a 103-nt syn-
thetic DNA template corresponding to the primer-binding
sequence and U5 segments of HIV-1 strain HXB2. Reac-
tions were assembled in reaction buﬀer (50 mM Tris–HCl
pH 8.3, 75mM KCl, 5mM MgCl2, 10mM DTT) with
30nM primer, 45nM template and 0.2mM dNTPs. After
annealing primer and template strands, DNA aptamers
were added. Reactions were initiated by adding RT to a
ﬁnal concentration of 3nM active site. For IC50 measure-
ments, ﬁnal aptamer concentrations were 0nM, 0.3nM,
1.0nM, 3.0nM, 10nM, 30nM, 100nM and 300nM. Addi-
tional reactions included 1mM and 3mM where indicated.
After 10min at 378C, reactions were quenched by addition
of 2 volumes (20ml) of gel-loading buﬀer (95% formamide
with 0.01% bromophenol blue). For reactions assessing
monovalent ion dependence, 75mM KCl was replaced
with 75mM NaCl where indicated.
Reaction products were separated using denaturing
(8M urea) 10% PAGE and scanned for ﬂuorescence
using a Fujiﬁlm FLA5000 imaging system. RT activity
data were collected using Fujiﬁlm Multi Gauge V2.3
image analysis software. Competitive inhibition by apta-
mers is due to a decrease in the concentration of available
enzyme, and is described by the two-state model for
RT-aptamer binding [Equation (1)]:
Y ¼ 100½aptamer =ðIC50 þ½ aptamer Þ 1
where Y is the measured percent activity at a given inhi-
bitor concentration. This equation can be rearranged to
a convenient form [Equation (2)] for curve-ﬁtting with
GraphPad Prism software to obtain IC50 values for apta-
mer inhibition:
Y ¼ 100=½1 þ 10ðlogIC50 XÞ  2
where X is the log of the inhibitor concentration. Error
terms for reported IC50 values are the standard deviations
among triplicate assays.
Circulardichroism spectroscopy
DNA aptamer samples (SN, RIT and RT6-B) were pre-
pared essentially as for inhibition assays, by heating to
908C and renaturing at 258C for 20min. The concentra-
tions 4mMo r2 mM were adjusted in the corresponding
buﬀers (K-buﬀer¼50mM Tris–HCl pH 8.3, 75mM KCl,
5mM MgCl2, 10mM DTT; Na-buﬀer¼50mM Tris–HCl
pH 8.3, 75mM NaCl, 5mM MgCl2, 10mM DTT). Near-
UV circular dichroism (CD) spectra were acquired at 258C
using an Aviv 62DS spectrometer (Lakewood, NJ) at
1.0nm intervals between 350nm and 210nm in a 1.0mm
quartz cuvette, averaging each data point for 10s.
RESULTS
Identification ofanovel inhibitory DNA structure
within ssDNA aptamers RT6, RT5and RT47
Aptamers RT5, RT6 and RT47 form a subgroup of closely
relatedsequenceswithin FamilyVIofthessDNAaptamers
identiﬁed by Schneider et al. (11). Consistent with previous
results, we obtained strong inhibition of DNA polymeriza-
tion by RT from a subtype B strain of HIV-1 by 80-nt
versions of each ofthese three aptamers. The concentration
required for half-maximal inhibition (IC50) by RT6 was
36 3nM and was similar for the other two (data not
shown). All three aptamers share the same sequence in
the ﬁrst 5–6nt of the initial 35N random segment
(Figure 1A), and this shared segment is complementary
to nucleotides within the 50-primer-binding constant
region. The remainder of each molecule includes four or
more stretches of guanosine tri-nucleotide repeats. Five
such repeats are evident in RT6. Aptamer RT6-A was gen-
erated by removing the 25nt on the 30-side of the fourth
repeat of RT6 and modifying 5nt between the third and
fourth repeat. Aptamer RT6-A was more than 2-fold more
potent for RT inhibition relative to the original RT6 apta-
mer (IC50¼16 3nM). Similar 30 deletions from RT5 and
RT47 inactivated these aptamers for RT inhibition unless
three guanosines were appended onto the 30-ends of the
truncated species to restore their original termini (data not
shown). Removing both the 30- terminal 25 nt and the
50-terminal three unpaired nucleotides (ACG) of RT6 gen-
erated a 53-nt species designated RT6-B that retained
potent RT inhibition (IC50¼5.7 0.8nM). Finally, the
41-nt aptamer variant R1T (IC50¼14 2nM, Figure 1C)
was generated in which the intra-quadruplex loop
sequences connecting the guanosine triplets in RT6-B
were replaced with single thymidine nucleotides. These
data suggest a structural model in which each of
these aptamers forms a 50-helical domain connected to a
30-guanosine quadruplex domain (Figure 1B).
Mutational support forquadruplexformation
To establish the quadruplex positions at which guanosine
is required, each of the nucleotides that are proposed
to deﬁne the G-quadruplex structures within RT6-A was
individually changed to adenosine. All 12 G-to-A substi-
tutions abolished RT inhibition (data not shown). These
data provide strong evidence that RT inhibition by RT6-A
(and by the original RT6) requires a three-tiered qua-
druplex. When similar mutations were generated in
R1T, 11 of the 12 G-to-A mutations were similarly dis-
ruptive. However, deleting the ﬁrst guanosine of the
second triplet or changing it to A, C or T only reduced
RT inhibition by two- to threefold (TQK4, Figure 2A, and
data not shown). These data suggest that only two tiers
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Oligos for activity assays 
Cy3Primer Cy3-GTCCCTGTTCGGGCGCCA 
103Template AAGTAGTGTGTGCCCGTCTGTTGTGTGACTCTGGTAACTAGAGATCCCTCAGACCCTTTT 
AGTCAGTGTGGAAAATCTCTAGCAGTGGCGCCCGAACAGGGAC
Full-length aptamers and terminal deletions
~35 RT5
~35 RT47
36±3 RT6
15±3 
5.7±0.8 RT6-B
ATCCGCCTGATTAGCGATACTCAGGCGCCgggGgggTgggAATACAGTGATCAGCGACTTGA  GCAAAATCACCTGCAgggg 
ATCCGCCTGATTAGCGATACTCAGGCCTTgggCgggCCgggACAATGGAGAGATTTACTTGA  GCAAAATCACCTGCAgggg 
ATCCGCCTGATTAGCGATACTCAGGCGTTAgggAAgggCGTCGAAAGCAgggTgggACTTGA  GCAAAATCACCTGCAgggg 
ATCCGCCTGATTAGCGATACTCAGGCGTTAgggAAgggTAGCGATACAgggTggg  
  CGCCTGATTAGCGATACTCAGGCGTTAgggAAgggCGTCGAAAGCAgggTggg  
R1T family  
14±2 R1T 
13±2 R2T 
~35 R4T 
20±3 R8T
  18±7 R1A 
>300 R2A 
>300 R4A 
>300 R8A
  26±9 R1C 
>300 R2C 
>300  R4C 
3.5±0.1 SN 
CGCCTGATTAGCGATACTCAGGCGTTgggTgggTgggTggg 
CGCCTGATTAGCGATACTCAGGCGTTgggTTgggTTgggTTggg 
CGCCTGATTAGCGATACTCAGGCGTTgggTTTTgggTTTTgggTTTTggg 
CGCCTGATTAGCGATACTCAGGCGTTgggTTTTTTTTgggTTTTTTTTgggTTTTTTTTggg 
CGCCTGATTAGCGATACTCAGGCGTTgggAgggAgggAggg 
CGCCTGATTAGCGATACTCAGGCGTTgggAAgggAAgggAAggg 
CGCCTGATTAGCGATACTCAGGCGTTgggAAAAgggAAAAgggAAAAggg 
CGCCTGATTAGCGATACTCAGGCGTTgggAAAAAAAAgggAAAAAAAAgggAAAAAAAAggg 
CGCCTGATTAGCGATACTCAGGCGTTgggCgggCgggCggg 
CGCCTGATTAGCGATACTCAGGCGTTgggCCgggCCgggCCggg 
CGCCTGATTAGCGATACTCAGGCGTTgggCCCCgggCCCCgggCCCCggg 
CGCCTGATTAGCGATACTCAGGCGTTggg(HEG)ggg(HEG)ggg(HEG)ggg 
Modifications to helical domain 
59±2 S1 
110±5 S2 
32±1 S4 
27±6 S5 
10.0±1.5 ZAM1
26±7 Srevstem
CGTGATTAGCGATACTCACGTTgggTgggTgggTggg 
CGGATTAGCGATACTCCGTTgggTgggTgggTggg 
CGCCTGAccctTCAGGCGTTgggTgggTgggTggg 
ATCCGCCTGATTAGCGATACTCAGAAGGAT TTgggTgggTgggTggg 
CGCCTGATTAGCGCGCGCCGCGTTTTCGCGGCGCGCGCTACTCAGGCGTTgggTgggTgggTggg 
CCGGACTCATAGCGATTAGTCCGGTTgggTgggTgggTggg 
Mutations establishing a three-tiered quadruplex 
>300 TQK1 
>300 TQK2 
>300 TQK3 
~40 TQK4 
>300 TQK5 
>300 TQK6 
RT6-A
>300 TQK7 
>300 TQK8 
>300 TQK9 
>300 TQK10
>300 TQK11
>300 TQK12
>300 ML2 
>300 ML4 
Topological variants 
>1000 Stem 
>1000 Q16 
~30 Dyl1 
~30 Dyl2 
~30 Dyl3
21.0±4 Dyl5
  22±4 Acut 
33±2  Acutrev 
48±1 Bcut 
99±2 Ecut 
>300 93del 
>300 Stem-93del 
CGCCTGATTAGCGATACTCAGGCG 
TgggTgggTgggTggg
CGCGCTACTCAGGCGTTgggTgggTgggTgggTTCGCCTGATTAGCGCG 
  CGCGCGCGCTACTCAGGCGTTgggTgggTgggTgggTTCGCCTGATTAGCGCGCGCG 
CGCGGCGCGCGCTACTCAGGCGTTgggTgggTgggTgggTTCGCCTGATTAGCGCGCGCCGCG 
CGCGCGCGCGCGCGGCGGCGCGCGCTACTCAGGCGTTgggTgggTgggTgggTTCGCCTGATT  AGCGCGCGCCGCCGCGCGCGCGCGCG
gggTgggTTCGCCTGATTAGCGATACTCAGGCGTTgggTggg 
gggTgggTTGCGGACTCATAGCGATTAGTCCGCTTgggTggg 
gggTTCGCCTGATTAGCGATACTCAGGCGTTgggTgggTggg 
gggTgggTgggTTCGCCTGATTAGCGATACTCAGGCGTTggg  
GggGTggGAggAGggT 
CGCCTGATTAGCGATACTCAGGCGTTGggGTggGAggAGggT 
Intermodule linker variants 
13±2 L3 
28±2 L4 
13±1 L6 
120±6 L10 
29±3 HEG 
CGCCTGATTAGCGATACTCAGGCGTTTTgggTgggTgggTggg 
CGCCTGATTAGCGATACTCAGGCGTTTTTTTTgggTgggTgggTggg 
CGCCTGATTAGCGATACTCAGGCGAAgggTgggTgggTggg 
CGCCTGATTAGCGATACTCAGGCGTTTTTTTTTTTTTTTTgggTgggTgggTggg 
CGCCTGATTAGCGATACTCAGGCG(HEG)gggTgggTgggTggg 
CGCCTGATTAGCGATACTCAGGCGTTAggTgggTgggTggg
CGCCTGATTAGCGATACTCAGGCGTTgAgTgggTgggTggg
CGCCTGATTAGCGATACTCAGGCGTTggATgggTgggTggg
CGCCTGATTAGCGATACTCAGGCGTTgggTAggTgggTggg
CGCCTGATTAGCGATACTCAGGCGTTgggTgAgTgggTggg
CGCCTGATTAGCGATACTCAGGCGTTgggTggATgggTggg
CGCCTGATTAGCGATACTCAGGCGTTgggTgggTAggTggg
CGCCTGATTAGCGATACTCAGGCGTTgggTgggTgAgTggg
CGCCTGATTAGCGATACTCAGGCGTTgggTgggTggATggg
TTAGCGATACTCAGGCGTTgggTgggTgggTAgg
TTAGCGATACTCAGGCGTTgggTgggTgggTgAg
TTAGCGATACTCAGGCGTTgggTgggTgggTggA 
CGCCTGATTAGCGATACTCAGGCGTTggTggTggTgg 
CGCCTGATTAGCGATACTCAGGCGTTggggTggggTggggTgggg 
CGCCTGA
CGCCTGA
CGCCTGA
Underlined nucleotides form the base-paired helical element; bold nucleotides comprise the guanosine triplet repeats.
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However, inserting or removing one guanosine from
each (TGGG) repeat in the original R1T quadruplex
to yield (TGGGG)4 in ML4 and (TGG)4 in ML2 prevents
aptamer-mediated RT inhibition (data not shown).
The potential signiﬁcance of these ﬁndings is discussed
below.
Sequence plasticity ofquadruplex loops and stem
To deﬁne further the sequence requirements within intra-
quadruplex loops, the single Ts in each loop of R1T were
changed to other sizes and sequences. Replacement with
single adenosines (R1A, IC50¼18 7nM, Figure 2B) or
cytidines (R1C, IC50¼26 9nM) was well tolerated,
R1T
300 100 30 10 3 1 0.3 0
No
RT
BC
RT5  atccgcctgattagcgatact CAGGCGCCGGGGGGGTGGGAATACAGTGATCAGCG acttgagcaaaatcacctgcagggg
RT6  atccgcctgattagcgatact CAGGCGTTAGGGAAGGGCGTCGAAAGCAGGGTGGG acttgagcaaaatcacctgcagggg
RT47 atccgcctgattagcgatact CAGGCCTTGGGCGGGCCGGGACAATGGAGAGATTT acttgagcaaaatcacctgcagggg
A
3′
5′
AGTCCGC
GATT
C
TCAGGCG
ATAC
G
G
G
G
GG
G
GG
GG
GG
T
T
stem
connector
Anti-parallel,
3-layer 
quadruplex
Figure 1. Quadruplex model for RT6 family of aptamers to HIV-1 RT. (A) Sequences of aptamers RT5, RT6 and RT47 from Schneider set (11).
Primer-binding sites for library ampliﬁcation are in lower case, 35N originally random nucleotides are in upper case, guanosine clusters are under-
lined. Note that all aptamers analyzed in this work are given in Table 1. (B) Generalized secondary structure of most aptamers studied in this work.
Stem and connector sequences shown are those of R1T, SN and several other aptamers. Intra-quadruplex loops are shown as curved lines. (C)
Inhibition of HIV-1 RT DDDP activity by aptamer R1T. Aptamer concentrations (nM) are indicated above the lanes. RT and primer/template
concentrations used in these assays are 3nM and 30nM, respectively. Open and ﬁlled arrows on the left indicate positions of unextended primer and
full-length product bands, respectively.
R1A
R2A
R8A
R4A
B
R2T
R1T
R8T
R4T
aptamer
300 100 30 10 3 1 0.3 0
No
RT
C
Zam1
100 30 10 0
No
RT 100 30 10
Srevstem R1T
100 30 10
TKQ4 R1T
300 100 30 10 300 100 30 10 0
No
RT
A
D
R1T SN
300 100 30 10 300 100 30 10 0
No
RT
E S4
300 100 30 10 3 1 0.3 0
No
RT
Figure 2. Sequence plasticity of stems and loops. Inhibition of RT DDDP activity by aptamer variants. Aptamer concentrations (nM) are indicated
above the lanes. (A) Aptamer TKQ4 retains inhibition even though it carries a G-to-A mutation in the fourth of the 12 G’s that comprise the
quadruplex. All other G-to-A variants were inactive for inhibition (data not shown). (B) Full concentration range of aptamers from 0.3nM to
300nM was used in establishing IC50 values for R1T variants in which quadruplex loops are replaced with multiple thymidines or multiple
adenosines. Similar titrations were carried out in triplicate for all aptamers for which IC50 values are reported. Aptamer R1T was included in
subsequent panels to provide a consistent reference baseline of inhibition. (C) RT inhibition by aptamer SN, in which quadruplex loops are replaced
with hexaethylene glycol. (D)and (E), RT inhibition by aptamers carrying mutations in helical stem domain, as detailed in text.
7128 Nucleic Acids Research, 2008, Vol. 36, No. 22while replacement with single guanosines was not (R1G,
IC50 250nM). Expanding the loops with runs of two
(R2T, IC50¼13 2nM), four (R4T, IC50 35nM) or
eight (R8T, IC50¼20 3nM) thymidines was also well-
tolerated. In contrast, expansion of the loops to two
(R2A), four (R4A) or eight (R8A) adenosines or with
two (R2C) or four (R4C) cytidines yielded aptamers
with greatly reduced capacity for inhibiting RT
(Figure 2B). To eliminate the possibility that RT-loop
nucleotide contacts are essential for aptamer recognition,
the intra-quadruplex loops were replaced with the rela-
tively inert, nonnucleosidic hexaethylene glycol (HEG)
to yield the SN aptamer. Interestingly, inhibition by
the SN aptamer is more than 10 times more potent
(IC50¼3.5 0.1nM, Figure 2C) than the original RT6,
and more than fourfold more potent than R1T. We con-
clude that speciﬁc loop nucleotides within the quadruplex
region are not required for inhibition or for stability, and
that the loops are only minimally constrained as to
sequence.
Additional variants of R1T were generated to identify
sequence constraints within the 7-bp stem comprising the
50-structural domain. Deletion of 2 bp (S1, IC50¼59 
2nM) or 3 bp (S2, IC50¼110 5nM) from the stem
progressively compromised RT inhibition (data not
shown), while lengthening the stem to 22 bp slightly
improved inhibition (ZAM1, IC50¼10.0 1.5nM).
Reversing the sequence orientation within this domain
(Srevstem, IC50¼26 7nM) had minimal impact on
IC50 (Figure 2D). Replacing the 10nt at the end
of the R1T stem with a CCCT tetraloop (S4,
IC50¼32 1nM, Figure 2E) had only a twofold eﬀect
on RT inhibition. These results establish that the
50-domain requires a generic double-helical fragment sta-
bilized by seven or more base pairs of essentially any
sequence.
Loop sequences affectsensitivity to ionic environment
Potassium ions strongly favor quadruplex formation,
while sodium ions are usually less stabilizing and lithium
ions are destabilizing (40,41). We observed equivalent
DNA polymerization activity by HIV-1 RT in buﬀers con-
taining either K
þ or Na
þ. RT inhibition by aptamers SN,
R1T and RT6-B was therefore monitored in the original
buﬀer containing K
þ and also in a buﬀer in which K
þ was
replaced with Na
þ. The same RT was nearly inactive in
buﬀers containing Li
þ, preventing analysis of inhibition in
the presence of Li
þ. All three aptamers strongly inhibited
RT in the presence of K
þ. Aptamers SN and R1T were
also strongly inhibitory in the Na
þ-containing buﬀer,
while aptamer RT6-B lost all inhibition under these
conditions (Figure 3). Because these three aptamers
diﬀer only in the loop sequences connecting the individual
guanosine triplets of the quadruplex, we conclude that
the loop sequences in RT6-B render that aptamer sensitive
to ionic destabilization, while the simpliﬁed structures
of R1T and SN stabilize those aptamers to ionic
substitution.
Circular dichroism (CD) spectroscopy is a powerful
analytical tool for identifying quadruplexes DNA struc-
tures. For quadruplexes in which all four strands are in
the same orientation (parallel), CD minima and maxima
are typically near 240nm and 264nm, respectively. For
quadruplexes in which strands orientation alternates
(antiparallel), the corresponding values are typically
near 265nm and 295nm, respectively. The CD spectra
for RT6-B and R1T both show maxima at 262nm and
minima at 242nm at room temperature in the presence of
K
þ (Figure 4). In Na
þ buﬀer the ellipticity is strongly
ﬂattened for RT6-B, especially at low DNA concentra-
tion, indicting destabilization of the quadruplex struc-
ture. Slight ﬂattening is also evident in R1T, although
to a lesser extent. Quadruplexes containing HEG loops,
such as the one in aptamer SN, have previously been
shown to be more stable than quadruplexes with single
T loops in both K
þ and Na
þ buﬀers (42); thus, SN is
also expected to retain its quadruplex in the Na
þ buﬀer.
These data provide independent conﬁrmation of guano-
sine quadruplex formation within the RT6 family of
aptamers, and they establish that the structural integrity
of the simple quadruplex within R1T is less sensitive to
ionic conditions, consistent with the inhibition data
above.
Ageneric, physical connection is requiredbetween
theduplex and quadruplex modules
RT inhibition was measured for several variants of R1T
to determine the importance of the physical connection
[K+]
[Na+]
R1T SN
300 100 30 10 300 100 30 10 0
No
RT 0
RT6-B
300 100 30 10
Figure 3. Loop sequences modulate ionic sensitivity. RT inhibition by aptamers RT6-B, R1T and SN was carried out in normal buﬀer (potassium as
the primary monovalent cation), or in buﬀers in which potassium was replaced with sodium. Note that in sodium, R1T eﬀected the most potent
inhibition.
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bition was observed for a 28-nt oligo containing only the
50 stem–loop motif (stem), nor for a 16-nt oligo containing
the (TGGG)4 quadruplex motif (Q16). Similarly, no
inhibition was observed when both oligos were added
simultaneously at a ratio of 1:1, even when their individual
concentrations were increased to 3000nM (Figure 5B).
A physical (covalent) connection between the DNA
duplex and G-quadruplex is therefore required to eﬀect
inhibition.
The stem–loop and G-quadruplex elements within apta-
mers RT6, RT5 and RT47 are joined by single-stranded
segments with the sequences TTA, CTT and CC, respec-
tively, while in R1T the connector is TT. To determine the
eﬀect of varying this connector sequence, RT inhibition
was measured for variants of R1T in which the connector
was changed to several other sequences. Changing those
two thymidines to two adenosines (A2 connector in L6), or
expanding it to four (T4 in L3) or eight (T8 in L4) thymi-
dines had minimal eﬀect on IC50 values (13 1, 13 2 and
28 2nM, respectively) (data not shown). To determine
whether the negative charges or other nucleic acid-related
features of these connector sequences are required for
RT inhibition, the duplex and quadruplex modules were
joined via HEG (Figure 5C). The IC50 value of the HEG-
linked molecule (29 3nM, HEG) is similar to that of the
T8-linked molecule. Thus, the primary role of the connec-
tor is to provide a physical connection between the two
domains, rather than to provide a speciﬁc structural or
functional role. However, there is an optimal range of
lengths for the connector, as increasing it to T16 signiﬁ-
cantly weakened inhibition (L10, IC50¼120 6nM).
Topological malleability ofthe connectivity between the
structural elements
In all of the aptamer variants above, the two structural
elements are connected via one ﬂexible linker between the
30-end of the helical element and the 50-end of the quad-
ruplex element. The 50- and 30-ends of the molecule are
located, respectively, at the termini of the helical and
quadruplex elements. Several variants of R1T were eval-
uated to determine whether alternative topologies are
allowed. To accommodate relocating the 50 and 30 termini
to other positions, the helical fragment was joined to the
quadruplex by separate thymidine dinucleotides at each
end of the quadruplex (Figure 5A). For variants Dyl1,
Dyl2, Dyl3 and Dyl5, the 50 and 30 termini lie within
the original loop at the distal end of the helical element.
The helical portions of these molecules contain a total of
15 bp, 19 bp, 22 bp or 35 bp, including an internal mis-
match derived from the original stem in RT6. All four
variants strongly inhibit HIV-1 RT (e.g. IC50¼21.0 
3.5nM for Dyl5) (Figure 5D). The 50 and 30 termini
were next relocated to internal positions within the quad-
ruplex (Figure 5A). Placing the 30-end after the second
guanosine triplet (Acut, IC50¼22 4nM, Figure 5D)
yielded inhibition within a factor of two of the potency
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the distal end of the helical element (Acutrev, IC50¼
33 2nM) had only a slight eﬀect on IC50. Inhibitory
potency was further reduced when the 30-end was placed
after the ﬁrst guanosine triplet (Bcut, IC50¼48 1nM) or
after the third guanosine triplet (Ecut, IC50¼99 2nM),
likely reﬂecting a destabilization of the quadruplex
module. Potent inhibitors based on R1T can therefore
be generated by joining the helical fragment and quadru-
plex by either a single or a double linker between the
helical and quadruplex elements.
Cross-clade inhibition ofdivergent primate lentiviral RT’s
The ssDNA aptamers studied here were originally
selected to bind RT from HIV-1 strain BH10 (group M,
subtype B). The inhibition studies presented above all
utilize RT from the closely related HIV-1 strain HXB2
(six amino acid diﬀerences in 560 positions, preserving
98.9% identity). To deﬁne the phylogenetic breadth of
inhibition by these bimodular ssDNA aptamers, DNA-
dependent DNA polymerization was monitored for a
panel of ﬁve RT variants from diverse primate lentiviral
strains from within HIV-1 group M (average 92% identity
with RT from BH10) and three from outside this group
(10). Aptamer SN was chosen for this analysis, as it was
the most potent inhibitor among those studied here. All
eight lentiviral RT’s were inhibited. With the exception of
the HIV-2 isolate, all IC50 values were (within error)
within a factor of two of being identical to IC50 for inhibi-
tion of the subtype B enzyme (Table 2). The SN aptamer
(and related forms) are therefore highly promising
reagents for developing broad-spectrum anti-HIV agents.
DISCUSSION
‘Universalist’, bimodular, single-stranded DNA aptamers
withstem-plus-quadruplex domains
This study demonstrates a novel structural paradigm for
bimodular DNA inhibitors of HIV-1 RT, in which one
module is a helical stem and the other is a guanosine
quadruplex. We identiﬁed this architecture within apta-
mers RT5, RT6 and RT47—isolated previously (11)—
and deﬁned the sequence components required to achieve
5′
3′
Dyl5
3′
Acut
5′
5′
3′ Stem Q16
+
5′
R1T
3′
Stem
0 No
RT
R1T Mix
3000
1000
300
Q16
0
3000
1000
300
3000
1000
300
300
100
30 3000
1000
300
Ctrl
A
B
C aptamer
300 100 30 10 3 1 0.3 0
No
RT
R1T
HEG
D aptamer
300 100 30 10 3 1 0.3 0
No
RT
Dyl5
Acut
Figure 5. Topological requirements. (A) Schematic diagrams of topological variants described in the text, assuming three-layer, parallel quadruplex
stacks. (B) RT inhibition assays utilizing separated subdomains of R1T (‘Stem’ and ‘Q16’). Inhibition is essentially eliminated when the two domains
are not physically connected. ‘Mix’ refers to a 1:1 mixture of stem and Q16 oligos, each at the indicated concentrations. ‘Ctrl’ is an irrelevant control
DNA: 50 d(GCGGGACAATGGAGAGAGGG). (C) RT inhibition assays in which the connector domain is replaced with HEG. (D) RT inhibition
assays in which inter-module connection is via two strands, with 50 and 30 termini in the stem module (Dyl5) or between the second and third
guanosine triplets (Acut).
Table 2. Inhibition of phylogenetically diverse primate lentiviral reverse
transcriptases
Strain Phylogenetic group
a Percent identity
b IC50 (nM)
HXB2 HIV-1 (M:B) 98.9 3.5 0.9
92UG021 HIV-1 (M:A/D)
c 92.9 3.0 0.3
98CN009 HIV-1 (M:C) 92.9 3.4 1.1
94CY017 HIV-1 (M:A) 90.4 7.2 0.7
93TH253 HIV-1 (M:A/E)
c 90.5 6.1 0.6
MVP5180 HIV-1 (O) 78.2 4.9 0.4
TAN1 SIVcpzP.t.s. 72.7 2.1 0.3
EHO-287 HIV-2 (B) 60.5 12.0 0.5
aHIV-1 phylogenetic groupings are designated by ‘(group:subtype)’.
bPercent amino acid identity in complete RT sequences in comparison
with HIV-1 strain BH10.
cStrains 93TH243 and 92UG021 are intersubtype recombinants. RT
from the former groups with subtype A; RT from the latter groups
with subtype D (10).
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a collection of 60 variants of RT6. Structural interpreta-
tions were further conﬁrmed by CD spectroscopy. The
most potent variant, designated SN, strongly inhibited
not only RT from HIV-1 subtype B, which was the sub-
type originally used in generating this family of aptamers,
but also several other HIV-1, SIVcpz and HIV-2 RT’s
ranging from approximately 60% to 92% amino acid
identity with RT from subtype B. Inhibition of these RT
and additional members of the RT diversity panel was
previously monitored for four RNA pseudoknot aptamers
(10) and for three ssDNA aptamers (14). ssDNA aptamer
RT8 was a ‘specialist’, exhibiting strict speciﬁcity for RT
from subtype B. In contrast, ssDNA aptamers RT1t49
and RT1t49(-5) were ‘universalists’ for primate lentiviral
RTs, inhibiting every member of the panel. The four RNA
aptamers displayed intermediate behavior, inhibiting
two or more members of the panel while leaving more
than half of the panel uninhibited. Thus, the ‘universalist’
inhibitory behavior of the bimodular aptamers studied
here (especially SN) is similar to that of RT1t49 and
RT1t49(-5).
Mutational analysis revealed a simple core structure
in these bimodular aptamers. The helical module can be
of any sequence. Internal bulges or mismatches are not
required; converting them into fully base paired sites
had no consequence on inhibition. Variants with seven
or more base pairs in the stem gave similar RT inhibition,
while variants with shorter stems were less eﬀective. The
distal end of this stem can either be a closed loop of
any sequence, or it can contain the 50 and 30 termini.
Mutations within the quadruplex module retained RT
inhibition, so long as the altered sequence retained the
capacity to form the quadruplex structure. Aptamer
R1T (IC50¼14 2nM), which may assume a two-layer
quadruplex (see below), yielded slightly weaker inhibition
than the three-layer quadruplex aptamers RT6-B (IC50¼
5.7 0.8nM) and SN (IC50¼3.5 0.1nM). Replacing the
T’s with HEG (SN) gave the strongest inhibition among
all variants tested here. We conclude that the duplex and
quadruplex structural modules, linked by a short tether,
are suﬃcient for potent inhibition of HIV-1 RT, and that
sequence-speciﬁc recognition plays little or no role in
specifying the protein–ssDNA interaction.
Interaction models forthe helical element
RT contains a strongly electropositive trough running
between the DNA polymerase and RNase H active sites
(43–45), which binds helical nucleic acids in co-crystal
structures and in modeled complexes (6,13,44,46–48).
The binding interactions of a dual-stem aptamer, denoted
RT1t49, have been modeled based on Fe(II)-mediated
DNA cleavage mapping (5). Diﬀerences in the hydroxyl
radical cleavage patterns in the presence of wild-type RT
and active site mutants suggested that the 50-end of
RT1t49 is near the polymerase active site, and that the
long stem of this aptamer extends towards the RNase H
active site (5). This model places the second structural
domain—a short duplex stem—on the back side of the
ﬁngers or thumb domain, perhaps close to the normal
trajectory of the 50 single-strand extension in the template
strand (49). A similar mode of interaction by the helical
domain of these bimodular aptamers would place the
quadruplex module on the back side of the ﬁngers or
thumb domain of RT.
Structure ofthe quadruplexelement
Our mutational and spectroscopic data support a quad-
ruplex with parallel strands of repeated guanosines
arranged into at least two stacked layers. All 12 guano-
sines were immutable within RT6-A, implying a three-
layer stack in this context. By extension, three stacked
layers are proposed for the original aptamers RT6-B,
RT6, RT5 and RT47. Adding or removing a guanosine
from each of the four repeats to shorten or extend the
stack within R1T abolished inhibition, again implying a
three-layer stack. In contrast, only 11 of the 12 guanosines
were strictly required in R1T. RT inhibition was reduced
but not abolished upon deletion or mutating the ﬁrst gua-
nosine of the second repeat within R1T to A, C or T,
potentially indicating that the nucleotide in this position
is translocated to the loop, and that only two stacked
layers are absolutely required in this context. An alterna-
tive possibility is that the three remaining guanosines in
this tier of the quadruplex may provide suﬃcient stabiliza-
tion to allow the fourth nucleotide to stack onto the quad-
ruplex so as to retain overall structure. Our results are also
in agreement with other authors’ ﬁndings that quadruplex
stability is aﬀected by the sequence of the loops (42,50).
In particular, the RT6-B aptamer inhibits RT only in
buﬀer that contains K
þ ions and shows considerable
broadening of its CD spectrum in buﬀer that contains
Na
þ, while the more compact R1T inhibits in both K
þ
and Na
þ, and shows less line broadening.
Some of the quadruplex modules included within these
bimodular aptamers are analogous to quadruplexes that
have been studied previously. A systematic survey of
quadruplexes with diﬀering numbers of repeated G’s or
with diﬀering loop sequences identiﬁed (G3T)4 as being
especially stable (51,52). The (G3T)4 quadruplex is very
similar to the (TG3)4 quadruplex within R1T. CD spectro-
scopy of (G3T)4 indicated parallel strands within the
stack (51), similar to the results obtained here for R1T
and RT6-B. In analogy with aptamer SN, the sequence
(G3-HEG)3G3 was previously shown to form a three-
tiered quadruplex and displayed greater thermal stability
than (G3T)4 (42). The (G3T)4 quadruplex—also referred to
as T30923 and as T30695—has been studied for inhibition
of HIV-1 integrase (53,54), in addition to structural stud-
ies (36,51–53). Importantly, an NMR structure of (G3T)4
shows only two layers of stacked guanosine tetrads with
partially ordered ‘GT’ loops (36,53). These observations
are consistent with the suggestion above that aptamer
R1T may only require two layers of stacked quadruplex.
However, the (TG3)4 quadruplex studied here (denoted
Q16 when used in isolation) was unable to inhibit RT
without a physical connection to the helical domain,
even when used at 3000nM concentration. The well-
studied aptamer ‘TBA’ (GGTTGGTGTGGTTGG)
forms a two-layer quadruplex that binds and inhibits
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preliminary assays, we observe no inhibition of thrombin-
mediated cleavage of a model, chromogenic peptide even
in the presence of 3000nM aptamer SN (data not shown),
suggesting that TBA may be a poor analog of SN. In sum,
most of the quadruplex modules within these aptamers are
best modeled as three-layered stacks of parallel strands,
in some cases with single-nucleotide or nonnucleic acid
loops, and we cannot rule out that two layers may be
suﬃcient for R1T.
Interaction modelsfor thequadruplex element
Aptamers with diverse quadruplex modules can accom-
plish RT inhibition, arguing for a promiscuous interaction
with the quadruplex domain. In particular, the intra-
quadruplex loops tolerate considerable plasticity. The
loops in aptamers RT5, RT47 and RT6 are unrelated to
each other. Inhibition was improved by simplifying the
loops to single A (R1A), C (R1C) or T residues (R1T)
and was further improved by replacing the loops with
HEG (SN). For each of these four alterations, inhibition
correlated with previously measured increases in the sta-
bilities of isolated quadruplex DNAs (42,51,52). Loop
substitutions with multi-homonucleotide sequences other
than T (R2C, R2A, etc.) did not inhibit RT. Furthermore,
aptamers with the phosphodiester chain termini located
within the quadruplex retained inhibition. Thus, the
loops are more likely to serve simply to stabilize the
folded quadruplex rather than to interact directly with
the protein.
The interaction model noted above for the helical
domain based on RT1t49 (5) places the quadruplex
module on the back side of the ﬁngers or thumb domain
of RT. An alternative interaction mode is suggested by
studies of two quadruplexes, 93del and (G3T)4, which
bind HIV-1 integrase. Integrase is in the same structural
superfamily as RNase H, with the greatest similarity in the
central catalytic core (IN residues 60–160) (55,56). In this
alternative model, the quadruplex domains of the bimod-
ular aptamers bind the RNase H domain of RT, eﬀectively
reversing the orientation of the helical domain relative to
the model suggested above. Quadruplex 93del (GGGGTG
GGAGGAGGGT) was originally selected as a longer
ODN93 for its ability to bind mature heterodimer
RT and not to bind a p51/p51 homodimer lacking
the RNase H domain (21). An NMR structure of 93del
shows an interlocking dimer of two three-layer quadru-
plexes, arranged in predominately parallel strands.
Those authors modeled the 93del dimer as docking into
the channel formed by HIV-1 IN, and they suggest poten-
tial interactions of the quadruplex loops with the protein
(55). Quadruplex (G3T)4 also binds and inhibits HIV-1 IN
(36,53,57,58). Shortening or extending the run of G’s
[(G2T)4 and (G4T)4, respectively] did not diminish IN inhi-
bition, a result that was interpreted as indicating DNA–IN
interaction through loops on the ends of the quadruplex,
rather than a side-on interaction (53). Computational
modeling of that interaction places the (G3T)4 quadruplex
in the catalytic domain of HIV-1 IN. Interestingly, this
NMR structure shows the guanosine triplets arranged
into antiparallel strands, even though CD analysis shows
an ellipticity maximum near 264nm, indicative of a par-
allel strand arrangement. Computational docking models
again suggest essential interactions between quadruplex
loops and the integrase catalytic core, particularly
Asp64, Asp116 and Glu152 (53).
The data and models from studies of these IN aptamers
are at odds with our RT inhibition studies with the bimod-
ular aptamers. Speciﬁcally, we observe similar degrees of
RT inhibition for a multitude of loop analogs, and RT
inhibition is disrupted by shortening [ML2, (TG2)4]o r
extending [ML4, (TG4)4] the run of G’s, in contrast with
the eﬀects of similar alterations within IN-binding quad-
ruplexes (55). Furthermore, a hybrid molecule carrying
the stem and connector elements and 93del in place of
the (TG3)4 quadruplex (stem-93del) did not inhibit RT
in pilot reactions. Thus, R1T and the members of the
RT6 family of ssDNA aptamers are structurally and func-
tionally distinct from previously described quadruplex
aptamers. While, it is possible that the quadruplex
domains of the bimodular aptamers interact with the
RNase H domain of RT, we conclude that the IN-binding
quadruplex models are not appropriate models for deﬁn-
ing this interaction. New experimental data are needed to
address this question directly.
CONCLUSION
The bimodular RT-binding aptamers presented here repre-
sent a novel architecture for RT antagonists. We demon-
strate that a helical fragment connected to diverse
quadruplex domains is able to specify the correct localiza-
tion and the strength of binding to RT protein, yielding
competition with primer/template for access to the protein.
The interactions appear distinct from those observed pre-
viously for quadruplex–integrase, quadruplex–thrombin
and quadruplex–RNase H complexes. It is likely that the
helical and quadruplex modules contact the protein
directly, and that their physical connection can facilitate
cooperativity of binding, with both modules interacting
simultaneously. Further, it is possible that simultaneous
binding at two sites, facilitated by a ﬂexible linker, aids
in the cross-clade recognition exhibited both by the stem-
plus-quadruplex bimodular aptamers studied here and by
the dual-stem aptamers studied previously (5,11,14).
Current work seeks to determine whether the bimodular
RT-binding aptamers described here confer antiviral
bioactivity in cell culture and whether they interact with
other cellular components. The results of those studies, and
those presented here, will aid the design of RT antagonists
for use in drug discovery and studies of HIV-1 replication.
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